| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.51 | 0.003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |